IP Verse

Eip competitive analysis

Explore patent oppositions filed by Eip against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026

Patent Number	Title	Applicant	Opposition Date
EP4185318	Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye Disorders	BAYER HEALTHCARE	Jun 3, 2026
EP3513663	Rebaudioside D Sweeteners And Food Products Sweetened With Rebaudioside D	PEPSICO	Jan 23, 2026
EP3996720	Injectable Nutritional Supplement	CHEMVET AUSTRALIA	Nov 12, 2025
EP4233846	Pharmaceutical Formulations	GILEAD SCIENCES	Sep 3, 2025
EP3592290	Delivery System For Transcatheter Prosthetic Heart Valves	EPYGON	Aug 27, 2025
EP4233973	Device For Arranging Guide Wires Around A Heart Valve	INNOVHEART	Aug 27, 2025
EP3226841	Anticancer Compositions	ARAGON PHARMACEUTICALS	Jul 9, 2025
EP2283851	Compositions And Methods For Promoting Hemostasis And Other Physiological Activities	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	Mar 6, 2024
EP3131504	Leaflet Abrasion Mitigation In Prosthetic Heart Valves	ST JUDE MEDICAL	Dec 15, 2023
EP3570779	Replacement Mitral Valves	CEPHEA VALVE	Nov 15, 2023

Discover the latest PTAB cases involving Eip, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Eip with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
EIP	20	-	-	-
ARAGON PHARMACEUTICALS	-	25	-	-
BAYER HEALTHCARE	-	21	-	1
VALVE MEDICAL	-	3	-	-